Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC expands Takeda’s Adcetris authorisation for Hodgkin lymphoma

pharmaceutical-technologyFebruary 14, 2019

Tag: EC , Takeda , Hodgkin lymphoma , ADCETRIS

PharmaSources Customer Service